Published in IBI on October 10, 2025, by Benjamin Wilkin
Wilkin, B., (2025) Comparing Organoids and Patient-derived Xenograft Models for the Development of Antibody-drug Conjugates - Crown Bioscience. https://blog.crownbio.com/comparing-organoids-and-patient-derived-xenograft-models-for-the-development-of-antibody-drug-conjugates
The final stage of drug discovery focuses on translational and clinical support, turning promising preclinical findings into successful human trials.…
Read more
Phase 2, of the drug discovery process, or preclinical development and optimization, is a critical stage in drug discovery. It bridges early lead…
Read more
Drug discovery is a journey defined by high stakes and complex challenges. From the initial identification of a target to the rigorous demands of…
Read more
